Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute of India, will be sold to the Indian government at Rs.200 per dose, SII head Adar Poonawalla has said.
For private buyers, Covishield will be sold to at a higher price of Rs.1000 per dose.
Adar Poonawalla said that the first 100 million doses of the Covid-19 vaccine are being sold to the Indian government at a “special price” of Rs 200 per dose, after which prices would be higher.
The Indian government gave emergency authorisation to the Oxford University-AstraZeneca, but on the condition that SII doesn’t export the shots to ensure that vulnerable populations in India are protected.
He said that the company also has been barred from selling the vaccine on the private market. “We can only give (the vaccines) to the government of India at the moment,” Adar Poonawalla said.
Adar Poonawalla added that the Serum Institute was in the process of signing a larger contract with Covax for 300 million-400 million doses of the vaccine.
Covax is an initiative created to ensure equitable access to Covid-19 vaccines set up by the World Health Organization, vaccines alliance GAVI and CEPI, a global coalition to fight epidemics.
By Joseph Maliakan Three terrible things that were inflicted especially on the poor and marginalized people…
Mr. Sajith Kumar P K : Along with Mr. Sajith Kumar, four other prominent leaders…
Sajith Kumar P.K : The Budget is touched to the Structural Reforms especially in Maritime…
By Joseph Maliakan The Institute of Liver and Biliary Sciences (ILBS) is a mono-super specialty…
By Joseph Maliakan In a judgment that will have far-reaching consequences for the protection of…
By Joseph Maliakan Education according to the Indian Constitution, is in the concurrent list and…
This website uses cookies.